Differences in the expression of p53 protein in oral lichen planus based on the use of monoclonal antibodies DO7 and pAb 240.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Oral Oncology

• Publication date

  2008-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.ORALONCOLOGY.2007.06.013PMID 17826304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Field cancerization in oral lichen planus.

  2007cited by this paper
• Epithelial p53 gene expression and mutational analysis, combined with growth fraction assessment, in oral lichen planus.

  2007cited by this paper
• Pathology & Genetics Head and Neck Tumours

  2007cited by this paper
• Significance of liquefaction degeneration in oral lichen planus: a study of its relationship with apoptosis and cell cycle arrest markers

  2007cited by this paper
• Analysis of p53 protein by PAb240, Ki-67 expression and human papillomavirus DNA detection in different types of odontogenic keratocyst.

  2006cited by this paper
• Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation.

  2006cited by this paper
• Dysplasia/neoplasia surveillance in oral lichen planus patients: a description of clinical criteria adopted at a single centre and their impact on prognosis.

  2006cited by this paper
• Cell cycle regulating mechanisms in oral lichen planus: molecular bases in epithelium predisposed to malignant transformation.

  2006cited by this paper
• High proliferative activity and chromosomal instability in oral lichen planus.

  2006cited by this paper
• Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis

  2005cited by this paper
• Epithelial precursor lesions

  2005cited by this paper
• Apoptosis and cell cycle arrest in oral lichen planus Hypothesis on their possible influence on its malignant transformation.

  2005cited by this paper
• Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis.

  2005cited by this paper
• Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation.

  2005cited by this paper
• Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.

  2005cited by this paper
• Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population.

  2004cited by this paper
• What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.

  2004cited by this paper
• Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence ?

  2004cited by this paper
• Implant dentistry: Clinical outcome of 103 consecutive zygomatic implants: a 6–48 months follow-up study

  2004cited by this paper
• The p53 network in head and neck cancer.

  2003cited by this paper
• The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective study.

  2003cited by this paper
• Cell proliferation activity and the expression of cell cycle regulatory proteins in oral lichen planus.

  2002cited by this paper
• Epithelial cell proliferation in oral lichen planus

  2002cited by this paper
• Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD.

  2002cited by this paper
• Oral lichen planus and malignant transformation: is a recall of patients justified?

  2002cited by this paper
• Identification of the AgNORs, PCNA and ck16 proteins in oral lichen planus lesions.

  2001cited by this paper
• Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: a 5-year experience.

  2001cited by this paper
• Identification of the AgNORs, PCNA and ck16 proteins in oral lichen planus lesions.

  2001cited by this paper
• Chronic immune activation and inflammation as the cause of malignancy

  2001cited by this paper
• Sequential immunohistochemical p53 expression in biopsies of oral lichen planus undergoing malignant evolution.

  2001cited by this paper
• Malignant transformation of oral lichen planus.

  1999cited by this paper
• Quantitative assessment of apoptosis in oral lichen planus.

  1999cited by this paper
• Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations.

  1999cited by this paper
• The possible association between oral lichen planus and oral squamous cell carcinoma: a clinical evaluation on 14 cases and a review of the literature.

  1998cited by this paper
• Increased number of proliferating cells in oral epithelium from smokers and ex-smokers.

  1998cited by this paper
• The p53 and nm23-H1 genes are not deleted in oral benign epithelial lesions.

  1998cited by this paper
• Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.

  1998cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• Apoptosis-associated markers in oral lichen planus.

  1997cited by this paper
• Oral Lichen Planus and Its Association With Squamous Cell Carcinoma: An Update on Pathogenesis and Treatment Implications

  1996cited by this paper
• High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.

  1995cited by this paper
• Assessment of p53 protein expression in normal, benign, and malignant oral mucosa

  1992cited by this paper
• Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library.

  1992cited by this paper
• Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.

  1990cited by this paper
• A Wilcoxon-type test for trend.

  1985cited by this paper

• A Molecular Hypothesis on Malignant Transformation of Oral Lichen Planus: A Systematic Review and Meta-Analysis of Cancer Hallmarks Expression in This Oral Potentially Malignant Disorder

  2024cites this paper
• Malignant transformation of oral lichen planus: where are we now?

  2024cites this paper
• Implications of p53 protein upregulation in oral lichen planus: a systematic review and meta-analysis

  2024cites this paper
• Beclin-1 as a potential prognostic marker in correlation with E-cadherin in oral lichen planus and oral squamous cell carcinoma: an immunohistochemical analysis

  2024cites this paper
• p53 Polymorphism in Oral Lichen Planus: A comprehensive review

  2022cites this paper
• Hallmarks of Cancer Expression in Oral Lichen Planus: A Scoping Review of Systematic Reviews and Meta-Analyses

  2022influential citation
• Role of Polymorphism of p53 Gene Codon 72 in HPV-associated oral lichen planus in south Indian population

  2022cites this paper
• Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: A systematic review and meta-analysis.

  2022cites this paper
• Dysplasia in oral lichen planus: relevance, controversies and challenges. A position paper

  2021cites this paper
• Inmunoexpresión de p53 y su relación con el grado de severidad en displasia epitelial oral.

  2021cites this paper
• Immunohistochemical Study of p53 Expression in Patients with Erosive and Non-Erosive Oral Lichen Planus

  2018cites this paper
• Expression and role of p53 in oral lichen planus patients.

  2017cites this paper
• Expression of survivin and p53 in oral lichen planus, lichenoid reaction and lichenoid dysplasia: An immunohistochemical study

  2017cites this paper
• Immunolocalization of substance P and NK-1 receptor in vascular anomalies

  2017cites this paper
• Increased nuclear localization of substance P in human gastric tumor cells.

  2017cites this paper
• Neuroendocrine factors: The missing link in non-melanoma skin cancer

  2017cites this paper
• Is oral cancer incidence among patients with oral lichen planus/oral lichenoid lesions underestimated?

  2017cites this paper
• Expression Analysis of p 53 and Cyclooxygenase-2 in Oral Lichen Planus

  2017cites this paper
• Comparative Evaluation of Imunohistochemical Expression of Ki-67 in Oral Lichen Planus , Oral Leukoplakia and Normal Mucosa Cases

  2015cites this paper
• p53 expression in oral lichenoid lesions and oral lichen planus.

  2015cites this paper
• Immunohistochemical Analysis of PCNA and P53 Proteins in Oral Lichen Planus, Lehadh M. Al – Azzawi Oral Dysplasia and Normal Oral Mucosa

  2014cites this paper
• Immunohistochemical expression of p53 and PCNA proteins in oral lichen planus and oral dysplasia

  2014cites this paper
• Evaluation of the expression of p53, MDM2, and SUMO-1 in oral lichen planus.

  2013cites this paper
• The Significance of p53 Immunoexpression with Different Clones (DO-7 and PAb-240) in Oral Squamous Cell Carcinoma

  2013cites this paper
• Molecular findings in oral premalignant fields: update on their diagnostic and clinical implications.

  2012cites this paper
• P53 and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma

  2012cites this paper
• Oral Lichen Planus as a Preneoplastic Inflammatory Model

  2012cites this paper
• The NK-1 receptor: a new target in cancer therapy.

  2011cites this paper
• A novel application of the buccal micronucleus cytome assay in oral lichen planus: a pilot study.

  2011cites this paper
• Oral lichen planus and the p53 family: what do we know?

  2011cites this paper
• Oral lichen planus and malignant transformation: a longitudinal cohort study.

  2011cites this paper
• AVALIAÇÃO DA EXPRESSÃO DAS PROTEÍNAS p53, MDM2 E SUMO-1 EM LÍQUEN PLANO BUCAL, DISPLASIA EPITELIAL BUCAL E CARCINOMA DE CÉLULAS

  2011cites this paper
• Codon72 polymorphism in the p53 tumor suppressor gene in oral lichen planus lesions in a Thai population.

  2010cites this paper
• Immunohistochemical study of syndecan-1 down-regulation and the expression of P35 protein in oral lichen planus: a clinicopathologic correlation with hepatitis C infection in the Egyptian population.

  2010cites this paper
• Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study.

  2010cites this paper
• Polymorphism of Tumor Protein p53 Codon 72 Showed No Association With Oral Lichen Planus in Shiraz, Iran

  2009cites this paper
• Liquen plano: Revisión de la literatura actual

  2009cites this paper
• Apoptosis and proliferation in oral lichen planus pigmentosus

  2009cites this paper
• Quantitative analysis of epithelial papillae in patients with oral lichen planus

  2009cites this paper
• Expression of substance P and neurokinin‐1‐receptor in laryngeal cancer: linking chronic inflammation to cancer promotion and progression

  2009cites this paper
• Substance P and NK-1R expression in oral precancerous epithelium.

  2009cites this paper
• IMMUNOHISTOCHEMISTRY ANALYSIS OF P53 AND KI-67 PROTEINS IN ORAL LICHEN PLANUS AND NORMAL ORAL MUCOSA

  2009cites this paper
• Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.

  2009cites this paper
• Human papillomavirus–associated recurrent plantar epidermal cysts in a patient after organ transplantation

  2009cites this paper